Pulmonary Fibrosis

Getting out of breath while walking, struggling to climb stairs, or having a dry cough that will not go away can make everyday activities feel increasingly difficult. These symptoms can have many causes, but when they result from pulmonary fibrosis, they may be linked to scarring inside the lungs. This scarring makes it harder for the lungs to expand and supply the body with the oxygen it needs.

Pulmonary fibrosis can develop for different reasons, and it does not affect everyone in the same way. Some people live with relatively stable symptoms for years, while others experience a gradual or faster decline in their breathing. Although existing lung scars generally cannot be removed, treatment can help manage symptoms and may slow the disease in certain cases.

Understanding the cause of the scarring and how it affects your lungs is an important step toward finding the right care.

What Is Pulmonary Fibrosis?

Pulmonary fibrosis is a condition in which scar tissue forms inside the lungs. The word pulmonary means related to the lungs, while fibrosis refers to the buildup of fibrous scar tissue.

To understand what happens, it helps to know how healthy lungs work. Your lungs contain millions of tiny air sacs called alveoli. When you breathe in, oxygen passes through the thin walls of these air sacs into your bloodstream. Your blood then carries oxygen to the rest of your body.

In a lung with pulmonary fibrosis, scar tissue develops in the delicate areas surrounding these air sacs. The affected tissue becomes thicker and stiffer, making it harder for the lungs to expand and for oxygen to pass into the blood. As a result, physical activities may become more tiring, and breathing may become increasingly difficult.

Pulmonary fibrosis is one of several lung scarring diseases. It can develop on its own as a specific disease or as part of another condition that affects the lungs. The amount of scarring, its location, and how quickly it develops all influence the symptoms a person experiences.

Pulmonary fibrosis is not the same for everyone. Identifying the type of disease helps doctors understand what may be causing the damage, whether it is likely to progress, and which treatments may be appropriate.

Types of Pulmonary Fibrosis

Doctors distinguish between types of pulmonary fibrosis based on their possible causes and how the lung tissue changes. Some forms develop without a known cause, while others are associated with another illness, medication, or exposure to harmful substances.

Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a type of pulmonary fibrosis in which doctors cannot identify the specific cause, even after carrying out the appropriate tests. The word idiopathic means that the cause is unknown.

IPF most often affects adults over the age of 50. The scarring can gradually make breathing more difficult, although the speed of progression varies considerably. Some people experience a slow decline, while others develop worsening symptoms over a shorter period.

Researchers believe that age, smoking history, and certain genetic factors may contribute to the risk of IPF. However, not everyone with these risk factors develops the disease, and many people diagnosed with IPF have no obvious explanation for why it occurred.

Pulmonary Fibrosis With a Known Cause

In some people, doctors can identify a condition or exposure that may have contributed to lung scarring. Examples include:

• Autoimmune diseases: Conditions such as rheumatoid arthritis and systemic sclerosis can cause the immune system to mistakenly attack the body's own tissues. In some people, this also damages the lungs.

• Workplace and environmental exposures: Repeatedly breathing in certain types of dust, mineral particles, or other harmful substances can injure lung tissue and lead to scarring.

• Certain medications: Some medicines can cause lung inflammation or damage as a side effect. A doctor may need to review the medication history to determine whether a treatment could be contributing to the problem.

• Radiation therapy: Radiation used to treat cancer in the chest can sometimes damage nearby lung tissue.

• Other lung diseases: Some conditions that initially cause inflammation in the lungs can eventually lead to permanent scarring.

Identifying the cause matters because treatment may involve managing the underlying illness, reducing exposure to a harmful substance, or addressing the scarring itself. The appropriate approach depends on the specific diagnosis.

Progressive Pulmonary Fibrosis

Progressive pulmonary fibrosis (PPF) describes a pattern in which lung scarring continues to worsen over time. It is not a separate disease and does not refer only to idiopathic pulmonary fibrosis. Several other types of lung disease can develop this pattern.

Doctors look for signs that the condition is getting worse, such as increasing breathlessness, declining results on breathing tests, or more extensive scarring on lung scans. They also consider whether another problem, such as an infection, could explain the changes.

Not everyone with pulmonary fibrosis develops progressive disease. Regular monitoring helps doctors recognize when the condition is changing and decide whether treatment needs to be adjusted.

What Causes Pulmonary Fibrosis?

Pulmonary fibrosis develops when the normal process of repairing damaged lung tissue results in too much scar tissue. Instead of returning to its usual flexible state, the affected tissue becomes thicker and less able to function normally.

In some cases, the cause is identifiable. In others, particularly idiopathic pulmonary fibrosis, it remains unknown. Factors that may increase the risk include:

• Age: Some forms of pulmonary fibrosis, especially IPF, are more common in older adults.

• Smoking: A history of smoking is associated with a higher risk of IPF and other lung diseases.

• Family history: Certain forms of pulmonary fibrosis occur more often in some families, suggesting that inherited factors may play a role.

• Autoimmune conditions: Diseases that affect the immune system and connective tissues can also affect the lungs.

• Long-term exposure to dust or other substances: Certain workplace and environmental exposures can damage lung tissue over time.

• Medication or radiation exposure: Some medicines and chest radiation treatments can cause lung injury in certain people.

Having one of these risk factors does not mean you will develop pulmonary fibrosis. The condition can also occur in people who have never smoked and have no known family history or harmful workplace exposure.

When the cause is unclear, a respiratory specialist may ask about your medical history, work environment, medications, and family history. This information helps determine which tests may be needed.

What Are the Symptoms of Pulmonary Fibrosis?

Pulmonary fibrosis symptoms often begin gradually. At first, you may notice that you become short of breath when walking uphill, climbing stairs, or carrying shopping. Activities that once felt easy may require more effort or more frequent breaks.

As the condition progresses, breathing difficulties may begin to affect routine tasks. Common symptoms include:

• Shortness of breath: You may feel out of breath during physical activity. As lung function declines, breathlessness can occur during lighter activities or, in more advanced disease, while resting.

• A persistent dry cough: The cough may continue for weeks or months and usually produces little or no mucus.

• Fatigue: When breathing requires more effort, you may feel unusually tired or have less energy for daily activities.

• Reduced stamina: Walking, doing housework, shopping, or exercising may become more difficult than before.

• Unintentional weight loss: Some people lose weight because eating becomes tiring or the body uses more energy for breathing.

• Changes in the fingertips: In some people, the fingertips become wider and rounder than usual. This is known as finger clubbing and can occur with certain long-term lung conditions.

Not everyone experiences all these symptoms. Their severity also does not always reflect exactly how much scarring is present. Some people have noticeable changes on a lung scan before they develop significant breathing problems.

These symptoms can occur with other conditions, including asthma, chronic obstructive pulmonary disease (COPD), heart disease, and respiratory infections. If you have persistent breathlessness or a cough that does not go away, seek medical advice rather than assuming that pulmonary fibrosis is the cause.

Sudden or severe breathlessness, chest pain, fainting, or a rapid worsening of breathing requires urgent medical assessment. These symptoms may indicate a serious complication or another condition that needs immediate treatment.

How Is Pulmonary Fibrosis Diagnosed?

Diagnosing pulmonary fibrosis involves finding out what has changed in the lungs, measuring how well they work, and investigating what may have caused the damage. No single test can identify every type of pulmonary fibrosis, so doctors usually combine several assessments.

An accurate diagnosis helps determine which treatments may be useful and gives doctors a starting point for monitoring the condition over time.

Medical History and Physical Examination

Your doctor will ask about your symptoms, when they began, and whether they have become more noticeable. You may also be asked about smoking, medications, previous illnesses, workplace exposures, and lung disease in your family.

During the examination, the doctor may listen to your lungs with a stethoscope and measure your blood oxygen level. Fine crackling sounds may sometimes be heard when lung tissue has changed, but these sounds alone cannot confirm pulmonary fibrosis.

Lung Scans

A chest X-ray may show signs of lung damage, but it may not reveal enough detail to identify the type or extent of scarring.

Doctors often use a high-resolution CT scan, commonly called an HRCT scan, to examine the lungs more closely. This scan uses X-rays to produce detailed images of the lung tissue. It can show where scarring is located and what pattern it follows.

Some patterns suggest idiopathic pulmonary fibrosis, while others may point to a different lung disease. Doctors compare the scan findings with your symptoms, medical history, and other test results before reaching a diagnosis.

Breathing and Oxygen Tests

Breathing tests help doctors measure how well your lungs are working. They can show whether the lungs have become less able to expand or transfer oxygen into the blood.

Depending on your symptoms, the assessment may include:

• Lung function tests: You breathe into a device that measures how much air you can move in and out of your lungs. Repeating these tests over time helps doctors track changes.

• Oxygen measurements: A small device placed on your finger estimates the amount of oxygen in your blood. Additional testing may be needed if your oxygen level falls during activity.

• Oxygen transfer testing: This measures how effectively oxygen passes from the lungs into the bloodstream.

• Walking or exercise tests: You may be asked to walk for a set period while your breathing and oxygen levels are monitored. This can reveal problems that are not obvious when you are sitting still.

These tests help doctors understand how pulmonary fibrosis affects your daily activities and whether you may need additional support, such as oxygen therapy.

Blood Tests and Lung Biopsy

Blood tests may help identify autoimmune diseases that can cause lung scarring. They may also be used to assess general health before treatment. Blood tests alone, however, cannot confirm every type of pulmonary fibrosis.

In some cases, doctors may consider a lung biopsy, which involves taking a small sample of lung tissue so it can be examined under a microscope. This may help when scans and other tests do not provide a clear diagnosis. A biopsy is not necessary for everyone because it involves risks, and doctors consider whether the results would change the treatment plan.

When the diagnosis is complex, respiratory specialists may review the scans and test results with radiologists and other relevant specialists.

Pulmonary Fibrosis Stages and Progression

People often search for pulmonary fibrosis stages to understand how serious the condition is and what may happen next. However, there is no single staging system that applies to every type of pulmonary fibrosis.

Instead, doctors assess how much the disease affects breathing, lung function, oxygen levels, and everyday activities. They also consider whether these findings are stable or getting worse.

In general, the condition may be described as early, moderate, or advanced:

• Early pulmonary fibrosis: Scarring may already be visible on a scan or detected through breathing tests, even if symptoms are mild. Breathlessness may occur mainly during exercise or more demanding activities.

• Moderate pulmonary fibrosis: Breathlessness and fatigue may interfere more often with everyday tasks. Breathing tests may show more noticeable changes.

• Advanced pulmonary fibrosis: Breathing may become difficult with very little activity or even at rest. Some people need supplemental oxygen, and complications may develop.

These descriptions are a general guide rather than formal stages that apply to everyone. Two people with similar scan results may have different symptoms and different needs for support.

How Quickly Does Pulmonary Fibrosis Progress?

The speed of progression depends on the type of pulmonary fibrosis and the individual. Some people experience gradual changes over many years, while others have a faster decline in lung function. In some cases, the condition remains stable for a period before getting worse.

Doctors monitor symptoms, breathing test results, oxygen levels, and lung scans to look for changes. If you notice that you are becoming more breathless than usual, tell your healthcare team rather than waiting for your next scheduled appointment.

Regular follow-up helps doctors identify progression and decide whether your treatment or monitoring plan needs to change.

Pulmonary Fibrosis Treatment

Pulmonary fibrosis treatment depends on what caused the scarring, how much the lungs are affected, and whether the condition is progressing. Although existing scar tissue usually cannot be removed, treatment may slow further damage in some forms of the disease, relieve symptoms, and help people remain active for as long as possible.

Not everyone needs the same treatment. Your doctor will consider your test results, other medical conditions, symptoms, and daily needs when discussing the available options.

Medicines That May Slow Lung Scarring

Certain medicines can slow the decline in lung function in people with specific forms of pulmonary fibrosis. These are called antifibrotic medicines. They act on processes involved in the development of scar tissue, but they do not remove scars that have already formed.

Two medicines used for idiopathic pulmonary fibrosis are:

• Nintedanib: This medicine can slow the rate at which lung function declines in people with IPF. It is also used for certain other progressive forms of fibrotic lung disease.

• Pirfenidone: This medicine is used to help slow the progression of IPF.

These medicines do not cure pulmonary fibrosis, and their benefits and side effects vary from person to person. Your specialist will explain whether treatment is appropriate, what side effects to watch for, and which checks are needed during treatment.

Treatment for the Underlying Cause

When pulmonary fibrosis is linked to another illness, treatment may also target that condition. For example, a person whose lung disease is associated with an autoimmune condition may need medicines to control the abnormal immune activity contributing to the problem.

If a medication or workplace exposure is suspected of damaging the lungs, the healthcare team may review ways to reduce the risk of further injury. Do not stop a prescribed medicine on your own; speak to the doctor managing your treatment first.

Not all forms of pulmonary fibrosis respond to the same medicines. Treatment needs to be based on the specific diagnosis, not simply on the presence of lung scarring.

Oxygen Therapy in Pulmonary Fibrosis

When the lungs cannot supply enough oxygen to the blood, a person may need supplemental oxygen. Oxygen therapy in pulmonary fibrosis provides extra oxygen through equipment such as small tubes placed in the nose or a mask connected to an oxygen source.

Some people need oxygen only during exercise or sleep, while others may need it for longer periods. The need for oxygen is determined through measurements of blood oxygen levels and, when appropriate, additional tests during activity.

Oxygen therapy can help maintain safer oxygen levels and may make physical activity more manageable when low oxygen is contributing to symptoms. However, it does not remove scar tissue or stop pulmonary fibrosis from progressing by itself.

Your doctor will determine whether oxygen is needed, how often it should be used, and what flow rate is appropriate. Follow the prescribed instructions and do not change the oxygen setting without medical advice.

Pulmonary Rehabilitation and Everyday Support

Pulmonary fibrosis can make physical activity more difficult, but the right support may help you maintain strength and manage daily tasks. Pulmonary rehabilitation is a supervised program designed for people with long-term lung conditions. It may include tailored exercise, breathing strategies, education, and advice on managing tiredness and breathlessness.

Your care plan may also include:

• Appropriate physical activity: A healthcare professional can help you choose activities that match your breathing ability and overall health.

• Stopping smoking and avoiding smoke: This helps protect the lungs from further irritation and damage.

• Maintaining good nutrition: Eating enough nutritious food helps preserve strength, especially if breathing difficulties make meals tiring.

• Vaccinations: Your healthcare team can advise you about vaccinations that help reduce the risk of certain respiratory infections.

• Managing other health conditions: Problems such as acid reflux, sleep difficulties, or complications affecting the blood vessels in the lungs may need separate treatment.

If everyday activities leave you breathless, ask your healthcare team how to pace tasks, take breaks, and conserve energy. The aim is to help you stay as active and independent as your condition allows.

Lung Transplantation

For some people with advanced pulmonary fibrosis, a lung transplant may be considered. This operation replaces one or both diseased lungs with donor lungs.

An organ transplant is not suitable for everyone. Doctors consider the severity of the disease, how quickly it is progressing, overall health, and other medical conditions. Assessment may begin before the disease reaches its most advanced stage because the evaluation process can take time.

A lung transplant can improve survival and quality of life for selected patients, but it is a major operation with significant risks. It also requires lifelong medication to help prevent the body from rejecting the transplanted lungs, along with regular medical follow-up.

Pulmonary Fibrosis Prognosis and Life Expectancy

Pulmonary fibrosis prognosis—the expected course of the disease—varies from person to person. The type of fibrosis, the amount of lung damage, changes in breathing test results, response to treatment, and development of complications can all affect the outlook.

Some people live with relatively stable disease for years, while others experience a more rapid decline. Idiopathic pulmonary fibrosis can be particularly serious because it often progresses over time, but the rate of progression is not the same for everyone. Other forms of pulmonary fibrosis may remain stable or respond to treatment when the underlying cause can be managed.

What Is the Life Expectancy With Pulmonary Fibrosis?

There is no single life expectancy or life span with pulmonary fibrosis that applies to everyone. Survival statistics describe groups of people, not what will necessarily happen to one individual.

When discussing life expectancy, doctors consider factors such as:

• The type of pulmonary fibrosis and its likely cause.

• How well the lungs are working and whether breathing test results are changing.

• The amount of scarring seen on lung scans.

• Blood oxygen levels and whether supplemental oxygen is needed.

• Other health conditions and possible complications.

• Overall health and response to treatment.

People sometimes search for information about living 20 years with pulmonary fibrosis. Some people can live for many years with certain forms of the disease, particularly when progression is slow. However, living 20 years cannot be guaranteed, and this timeframe may not reflect the course of more aggressive forms such as IPF.

A diagnosis does not, by itself, tell you exactly how much time you have. Your specialist can explain what your test results suggest, whether the disease appears stable or progressive, and which treatment options may help. It is also reasonable to ask what changes to watch for and when to seek medical advice.

Is Pulmonary Fibrosis Hereditary?

Pulmonary fibrosis is not always hereditary, but genetic factors can play a role in some cases. Most people diagnosed with the condition do not have a clearly established inherited cause. However, some families have more than one member with pulmonary fibrosis, a pattern known as familial pulmonary fibrosis.

Having a close relative with pulmonary fibrosis may increase your risk, but it does not mean you will necessarily develop the condition. Many people with pulmonary fibrosis have no known family history of the disease.

If several people in your family have been diagnosed, or if the disease develops at an unusually young age, your doctor may recommend further assessment or genetic counseling. Genetic counseling helps people understand whether an inherited factor may be involved and whether genetic testing could be useful. Testing is not necessary for everyone with pulmonary fibrosis.

If you are concerned about your family history, tell your doctor which relatives were affected and, if you know, what type of lung disease they had. This information can help determine whether further evaluation is appropriate.

Pulmonary Fibrosis vs. Cystic Fibrosis: What Is the Difference?

Pulmonary fibrosis and cystic fibrosis have similar names, but they are different conditions. Understanding the difference is important because their causes, effects on the lungs, and treatments are not the same.

Pulmonary fibrosis refers to scarring inside the lungs. It can develop for several reasons, including IPF, autoimmune disease, certain medications, or exposure to harmful substances. The scar tissue makes the lungs stiffer and can make it harder for oxygen to pass into the blood.

Cystic fibrosis is an inherited genetic condition caused by changes in a gene called CFTR. This gene helps control the movement of salt and water in and out of cells. When it does not work properly, thick, sticky mucus builds up in the lungs and other organs. In the lungs, the mucus can trap germs, leading to repeated infections and long-term damage.

Although severe lung damage from cystic fibrosis can eventually include scarring, cystic fibrosis is not another name for pulmonary fibrosis. The two conditions have different underlying causes and require different approaches to diagnosis and treatment.

Why Choose Medical Park for Pulmonary Fibrosis Evaluation and Treatment?

Medical Park's Chest Diseases (Pulmonology) departments provide evaluation and treatment planning for patients with suspected or diagnosed pulmonary fibrosis in Turkey. Our specialists can review your symptoms, medical history, previous reports, lung scans, and breathing test results to help identify the type of lung disease and determine the next steps.

Depending on the diagnosis, care may include monitoring lung function, discussing suitable medication, assessing whether oxygen therapy is needed, and arranging support for symptoms that affect everyday life. When pulmonary fibrosis is associated with another medical condition, other relevant specialists may be involved according to the patient's needs. Follow-up appointments help the medical team assess changes over time and review the treatment plan when necessary.

For international patients, Medical Park's International Patient Services Center can assist with arranging specialist consultations, diagnostic investigations, treatment planning, and follow-up during care in Turkey. Patients can share their existing medical reports and discuss their individual concerns with the medical team to better understand the diagnosis and available treatment options.